Pegaptanib for wet macular degeneration

Pegaptanib sodium injection (Macugen, Eyetech Pharmaceuticals, Pfizer, New York, NY, USA) is a relatively new medication intended to treat the so-called wet (neovascular ) form of age-related macular degeneration (AMD). This form of AMD is characterized by the growth of unwanted new blood vessels in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs of Today 2005-11, Vol.41 (11), p.703-709
1. Verfasser:	Fraunfelder, Frederick W
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Angiogenesis Inhibitors - pharmacology Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Aptamers, Nucleotide - adverse effects Aptamers, Nucleotide - pharmacokinetics Aptamers, Nucleotide - pharmacology Aptamers, Nucleotide - therapeutic use Choroidal Neovascularization - drug therapy Choroidal Neovascularization - pathology Choroidal Neovascularization - therapy Clinical Trials as Topic Humans Light Coagulation Macular Degeneration - drug therapy Macular Degeneration - pathology Macular Degeneration - therapy Molecular Structure Photochemotherapy Ranibizumab Vascular Endothelial Growth Factor A - antagonists & inhibitors Vitamins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!